Chardan Downgrades Regeneron Pharmaceuticals, Notes Valuation Concerns By: Benzinga via Benzinga August 31, 2015 at 13:31 PM EDT Gbola Amusa, Chardan Capital Markets' head of healthcare research, commented in a note on Monday that investors should be "more ... Read More >> Related Stocks: Regeneron Pharmaceuticals